Developer docs
API playgroundTry for free, no card

Search company profiles

EyeQue

Full company profile

uuid00021b6

Namestring
EyeQue
Legal namestring
EyeQue Corporation
Websiteurl
eyeque.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

EyeQue Corporation is a Newark, California-based digital health company founded in 2015 by MIT-trained physicist John A. Serri (CEO) and technology veteran Noam Sapiens (President and CTO). The company develops smartphone-based vision testing hardware and software that allow consumers to measure refractive error, pupillary distance, color vision, and visual acuity at home without visiting an optometrist. Its flagship product, VERAI (launched spring 2025), combines a proprietary optical attachment with adaptive AI algorithms to deliver refraction measurements and prescription-ready outputs, supported by MIT-licensed core technology and 25 issued patents (35 total with pending applications). The technology stack is anchored by an FDA-registered, HIPAA-compliant, SOC2-certified cloud platform branded EyeQue Connect that exposes an Open API for EHR integration.

EyeQue operates a hybrid go-to-market. Free mobile apps (PDCheck AR, MyReaderNumber, Color Vision Test, Visual Acuity Test) drive top-of-funnel user acquisition through the Apple App Store and Google Play. Paid hardware — VERAI at $129, PDCheck at $15, and the Insight Lite screening kit — converts users via direct e-commerce on eyeque.com, while a $29/year Tracking Service subscription provides recurring revenue and ongoing vision monitoring. On the B2B side, EyeQue monetizes through white-label and licensing arrangements with optical retailers, telemedicine providers, hospitals, and educational institutions, including a strategic partnership with Zenni Optical and an alliance with Access Care. The company reports more than 100,000 customers served across 150+ countries and has been recognized with CES Innovation Awards in 2017, 2019, 2020, and 2021, plus T100 and USA Today Top Companies accolades.

Financially, EyeQue has raised approximately $57 million across three disclosed funding rounds ($5M in 2015, $11.2M in 2018, and $40.8M in 2021), operates with a lean team of 11–50 employees from its Newark headquarters, and ships devices globally while running the EyeQue Connect SaaS platform on AWS. No acquisitions, M&A, or restructuring events have been disclosed, and the company remains private with founder-led ownership.

Short descriptiontext

EyeQue Corporation, founded in 2015 and based in Newark, California, develops smartphone-based vision testing hardware and AI-powered refraction software — including its flagship VERAI device — that enables consumers to measure refractive error, pupillary distance, and visual acuity at home, serving individual consumers, optical retailers, telemedicine providers, and healthcare organizations across more than 150 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNewark, United States
HQ citystring
Newark
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
smartphone vision testing, at-home refraction devices, telehealth eye care, AI vision screening, pupillary distance measurement
Industry2 codes
PRIMARYHLAHAJAC
Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
SECONDARYHLALAGAL
Ophthalmology & Vision Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Ophthalmic Goods Manufacturing339115
SIC code1 code
  • Ophthalmic Goods3851
Product category
Consumer Digital Health Vision Testing
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Hardware Device Sales
TypeHardware Sales
Description

EyeQue sells proprietary vision testing devices including VERAI (refraction tester) and PDCheck (pupillary distance meter) as one-time purchases. Devices range from $15 to $129, enabling consumers to perform professional-grade vision tests at home.

2Subscription Services
TypeSubscription Recurring
Description

Annual subscription service ($29/year) provides ongoing vision tracking and prescription monitoring. Users receive regular updates on vision changes and can obtain updated prescriptions through the platform.

3Telehealth and Prescription Services
TypeProfessional Services
Description

EyeQue Connect platform enables telehealth consultations where users can receive valid prescriptions based on their test results, generating revenue from prescription issuance and related services.

4B2B Licensing and White Labeling
TypeLicensing Royalties
Description

Enterprise licensing arrangements with optical retailers, online eyeglass providers, digital health platforms, and telemedicine companies. Partners can white-label EyeQue's technology for their own customer bases.

Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Pricing details7 tiers
1VERAI - At-home refraction measurement device
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$129 one-time purchase. Includes the VERAI device for measuring nearsightedness, farsightedness, and astigmatism with clinically validated accuracy.

2PDCheck - Pupillary distance measurement device
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$15 one-time purchase. Measures pupillary distance for accurate eyeglass fitting.

3Vision Tracking Service - Annual subscription
ModelSubscriptionBilling cadenceAnnual
Notes

$29 per year. Provides ongoing vision tracking, prescription updates, and access to EyeQue Connect telehealth platform.

4MyReaderNumber - Free iOS app
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free download (iOS only). Basic reading magnifier and near vision test functionality.

5PDCheck AR - Free iOS app
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free download (iOS only). Augmented reality pupillary distance measurement.

6Free Vision Tests - Color and Visual Acuity
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free color vision test and visual acuity test apps available for all users.

7Try-On Glasses - Virtual try-on feature
ModelFreemiumBilling cadencePay-as-you-go
Notes

Pricing not specified. Virtual eyeglass try-on feature integrated with product catalog.

GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 9 records shown
1VERAI
Description

Virtual Evaluation of Refraction with AI - AI-powered at-home vision testing device with doctor-reviewed prescriptions and Try-On glasses

eyeque.com
+8 more records
Core offering1 text field

EyeQue designs and sells smartphone-powered, AI-based at-home vision testing hardware and software, anchored by the VERAI refraction device. Its portfolio includes the Insight Lite screener, PDCheck and PDCheck AR pupillary distance tools, MyReaderNumber reading vision app, Try-On Glasses, the Tracking Service subscription, and the HIPAA-compliant EyeQue Connect telehealth platform with Open API for EHR integration, enabling consumers and partners to measure, track, and obtain prescriptions remotely.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 95% of users achieve 20/20 visual acuity or better
+2 more records
Product overview1 text field

EyeQue is a digital health company offering a comprehensive at-home vision testing ecosystem built around its AI-powered VERAI device. The product portfolio includes hardware devices (VERAI, Insight Lite, PDCheck), mobile apps (PDCheck AR, MyReaderNumber), and the EyeQue Connect telehealth platform for doctor-reviewed prescriptions. Complementary services include Try-On Glasses for prescription testing, Tracking Service for ongoing vision monitoring, and free online vision screening tools (Color Vision Test, Visual Acuity Test). All products integrate with the HIPAA-compliant EyeQue Connect platform, enabling patients to track vision health over time and connect with eye care providers remotely.

Product and service11 records
1EyeQue VERAI
CategoryAI Vision Testing Hardware
Description

AI-powered at-home refraction measurement device that attaches to a smartphone and delivers clinically accurate DIY vision tests, producing doctor-reviewed prescriptions and Try-On glasses. Uses MIT-licensed adaptive AI technology with 24 granted patents.

2EyeQue Insight Lite
CategoryVision Screening Hardware
Description

Pocket-sized vision screening device for at-home eye testing, measuring visual acuity, color vision, and contrast sensitivity with a portable form factor designed for frequent vision monitoring.

3EyeQue PDCheck
CategoryPupillary Distance Hardware
Description

Physical pupillary distance measurement device consisting of a frame and app that uses a smartphone camera and selfie analysis to measure PD within 1mm accuracy for eyeglass fitting.

4EyeQue PDCheck AR
CategoryVision Testing Mobile App
Description

Free iOS app using Augmented Reality to instantly measure near and far pupillary distance, including right and left PD, using only an iPhone.

5EyeQue MyReaderNumber
CategoryVision Testing Mobile App
Description

iOS app that provides instant personalized near and mid-distance vision measurements for reading glasses using patented technology to measure reading and computer power for each eye individually.

6EyeQue Try-On Glasses
CategoryVision Testing Accessory
Description

Single vision test glasses that allow users to try their refraction numbers before purchasing expensive prescription glasses, shipped with the EyeQue Insight Lite for visual acuity confirmation.

7EyeQue Tracking Service
CategoryVision Tracking Subscription
Description

Annual subscription service ($29/year) that tracks all vision measurements over time including refraction results (Sphere, Cylinder, Axis), PD measurements, and vision screening data (Visual Acuity, Contrast Sensitivity, Color Testing); HIPAA compliant.

8EyeQue Connect
CategoryTelehealth SaaS Platform
Description

FDA-registered, SOC2 and HIPAA-compliant telehealth SaaS platform that connects doctors and patients for remote vision care, with features including vision monitoring and tracking, virtual consultations, prescription management, automated reporting, and Open API EHR integration.

9EyeQue Prescription Renewal
CategoryTelehealth Service
Description

Telehealth service enabling users to renew their prescription from home through a virtual consultation with a board-certified doctor based on EyeQue test results.

10EyeQue Color Vision Test
CategoryVision Testing Online Tool
Description

Free online color vision screening test that checks for red-green deficiencies (deuteranopia and protanopia) in 60 seconds, accessible without account login.

11EyeQue Visual Acuity Test
CategoryVision Testing Online Tool
Description

Free online visual acuity test using Snellen Chart methodology, accessible on desktop/laptop in under 5 minutes without requiring an account.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

EyeQue founder Tibor Laczay discussed collaboration opportunities with Zenni Optical, a major online eyeglass retailer, for integrating vision testing capabilities with prescription eyeglass services. This partnership would enable Zenni customers to obtain updated prescriptions using EyeQue technology.

2Access Care
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Groundbreaking alliance announced for providing vision care services. Access Care partnership enables expanded reach into specific market segments requiring vision care solutions.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Mentioned in alliance context with Access Care. Nature of partnership appears to involve distribution or retail presence for EyeQue products.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Partnerships with optical retail stores for distribution, white labeling, and integration of EyeQue vision testing technology. Stores can offer EyeQue devices and telehealth services to their customers.

Strategic tierCoreTypeTechnology or Integration
Description

Integration partnerships with telemedicine platforms to offer remote vision testing and prescription services. EyeQue Connect platform enables telehealth consultations.

Strategic tierCoreTypeTechnology or Integration
Description

Partnerships with hospitals and healthcare systems to provide scalable vision screening solutions. HIPAA-compliant infrastructure enables secure healthcare data handling.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnerships with schools for vision testing programs, providing accessible eye care screening for students.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Visibly offers online refraction and prescription renewal services directly to consumers, the closest direct competitor to EyeQue's at-home vision testing model with doctor-reviewed prescriptions.

TypeDirect peer
Description

20/20 Now provides online eye exams and refraction services partnering with optical retailers, directly overlapping EyeQue's telehealth vision testing and B2B white-label offerings.

TypeBroad incumbent
Description

Warby Parker is an established direct-to-consumer eyewear retailer that has expanded into virtual try-on, prescription apps, and telehealth, competing with EyeQue on the consumer vision testing journey.

TypeBroad incumbent
Description

Zenni Optical is a major online eyeglass retailer; EyeQue has discussed partnership with them, and both companies target the prescription-eyewear self-service consumer segment.

TypeBroad incumbent
Description

1-800 Contacts is the largest online contact lens retailer and has expanded into online vision testing and prescription renewal, overlapping with EyeQue's telehealth vision services.

6eyeBuyDirect
TypeBroad incumbent
Description

eyeBuyDirect is a major online eyewear retailer offering prescription glasses; they have explored virtual try-on and prescription tools, overlapping with EyeQue's consumer vision testing value chain.

TypeBroad incumbent
Description

LensCrafters is a large traditional optical retail chain owned by EssilorLuxottica, increasingly integrating digital refraction and telehealth into in-store and online experiences that compete with EyeQue's model.

TypeBroad incumbent
Description

SmartBuyGlasses is an online eyewear retailer with a global presence offering prescription glasses; their digital try-on and prescription tools place them in the same consumer vision care space as EyeQue.

TypeEmerging player
Description

Hims & Hers has expanded into vision and eye care telehealth through online prescription eyewear, representing an emerging competitor in the broader digital vision care category.

10RxDefine
TypeEmerging player
Description

RxDefine provides online vision testing and telehealth refraction services integrated with optical retail partners, an emerging player operating in a similar niche as EyeQue's telehealth vision testing.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

EyeQue

Consumer Digital Health Vision Testingeyeque.com

EyeQue Corporation, founded in 2015 and based in Newark, California, develops smartphone-based vision testing hardware and AI-powered refraction software — including its flagship VERAI device — that enables consumers to measure refractive error, pupillary distance, and visual acuity at home, serving individual consumers, optical retailers, telemedicine providers, and healthcare organizations across more than 150 countries.

What EyeQue does

EyeQue Corporation is a Newark, California-based digital health company founded in 2015 by MIT-trained physicist John A. Serri (CEO) and technology veteran Noam Sapiens (President and CTO). The company develops smartphone-based vision testing hardware and software that allow consumers to measure refractive error, pupillary distance, color vision, and visual acuity at home without visiting an optometrist. Its flagship product, VERAI (launched spring 2025), combines a proprietary optical attachment with adaptive AI algorithms to deliver refraction measurements and prescription-ready outputs, supported by MIT-licensed core technology and 25 issued patents (35 total with pending applications). The technology stack is anchored by an FDA-registered, HIPAA-compliant, SOC2-certified cloud platform branded EyeQue Connect that exposes an Open API for EHR integration.

EyeQue operates a hybrid go-to-market. Free mobile apps (PDCheck AR, MyReaderNumber, Color Vision Test, Visual Acuity Test) drive top-of-funnel user acquisition through the Apple App Store and Google Play. Paid hardware — VERAI at $129, PDCheck at $15, and the Insight Lite screening kit — converts users via direct e-commerce on eyeque.com, while a $29/year Tracking Service subscription provides recurring revenue and ongoing vision monitoring. On the B2B side, EyeQue monetizes through white-label and licensing arrangements with optical retailers, telemedicine providers, hospitals, and educational institutions, including a strategic partnership with Zenni Optical and an alliance with Access Care. The company reports more than 100,000 customers served across 150+ countries and has been recognized with CES Innovation Awards in 2017, 2019, 2020, and 2021, plus T100 and USA Today Top Companies accolades.

Financially, EyeQue has raised approximately $57 million across three disclosed funding rounds ($5M in 2015, $11.2M in 2018, and $40.8M in 2021), operates with a lean team of 11–50 employees from its Newark headquarters, and ships devices globally while running the EyeQue Connect SaaS platform on AWS. No acquisitions, M&A, or restructuring events have been disclosed, and the company remains private with founder-led ownership.

EyeQue firmographics

Firmographics
Name
EyeQue
Legal name
EyeQue Corporation
Website
https://eyeque.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
EyeQue Corporation, founded in 2015 and based in Newark, California, develops smartphone-based vision testing hardware and AI-powered refraction software — including its flagship VERAI device — that enables consumers to measure refractive error, pupillary distance, and visual acuity at home, serving individual consumers, optical retailers, telemedicine providers, and healthcare organizations across more than 150 countries.
Ownership category
akta.pro rank

EyeQue industry classification

Industry
Product category
Consumer Digital Health Vision Testing
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Ophthalmic Goods Manufacturing (339115)
SIC
Ophthalmic Goods (3851)
akta.pro industry
PRIMARYHLAHAJAC
Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
SECONDARYHLALAGAL
Ophthalmology & Vision Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)

Keywords

  • Smartphone vision testing
  • At-home refraction devices
  • Telehealth eye care
  • AI vision screening
  • Pupillary distance measurement

Where EyeQue is headquartered

Location

Headquarters

HQ city
Newark
HQ country
United States
HQ region
North America

Offices1 record

Markets served

EyeQue business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. Hardware Device Sales: EyeQue sells proprietary vision testing devices including VERAI (refraction tester) and PDCheck (pupillary distance meter) as one-time purchases. Devices range from $15 to $129, enabling consumers to perform professional-grade vision tests at home.
  2. Subscription Services: Annual subscription service ($29/year) provides ongoing vision tracking and prescription monitoring. Users receive regular updates on vision changes and can obtain updated prescriptions through the platform.
  3. Telehealth and Prescription Services: EyeQue Connect platform enables telehealth consultations where users can receive valid prescriptions based on their test results, generating revenue from prescription issuance and related services.
  4. B2B Licensing and White Labeling: Enterprise licensing arrangements with optical retailers, online eyeglass providers, digital health platforms, and telemedicine companies. Partners can white-label EyeQue's technology for their own customer bases.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goVERAI - At-home refraction measurement device
Unit PricingPay-as-you-goPDCheck - Pupillary distance measurement device
SubscriptionAnnualVision Tracking Service - Annual subscription
FreemiumPay-as-you-goMyReaderNumber - Free iOS app
FreemiumPay-as-you-goPDCheck AR - Free iOS app
FreemiumPay-as-you-goFree Vision Tests - Color and Visual Acuity
FreemiumPay-as-you-goTry-On Glasses - Virtual try-on feature

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

EyeQue product offering

Product offering

Core offering

EyeQue designs and sells smartphone-powered, AI-based at-home vision testing hardware and software, anchored by the VERAI refraction device. Its portfolio includes the Insight Lite screener, PDCheck and PDCheck AR pupillary distance tools, MyReaderNumber reading vision app, Try-On Glasses, the Tracking Service subscription, and the HIPAA-compliant EyeQue Connect telehealth platform with Open API for EHR integration, enabling consumers and partners to measure, track, and obtain prescriptions remotely.

Product overview

EyeQue is a digital health company offering a comprehensive at-home vision testing ecosystem built around its AI-powered VERAI device. The product portfolio includes hardware devices (VERAI, Insight Lite, PDCheck), mobile apps (PDCheck AR, MyReaderNumber), and the EyeQue Connect telehealth platform for doctor-reviewed prescriptions. Complementary services include Try-On Glasses for prescription testing, Tracking Service for ongoing vision monitoring, and free online vision screening tools (Color Vision Test, Visual Acuity Test). All products integrate with the HIPAA-compliant EyeQue Connect platform, enabling patients to track vision health over time and connect with eye care providers remotely.

Differentiator

Problem solved

Functional benefit

Brands

  • VERAI: Virtual Evaluation of Refraction with AI - AI-powered at-home vision testing device with doctor-reviewed prescriptions and Try-On glasses
  • EyeQue Insight Lite
  • EyeQue PDCheck
  • EyeQue PDCheck AR
  • EyeQue MyReaderNumber
  • EyeQue Try-On Glasses
  • EyeQue Tracking Service
  • EyeQue Connect
  • EyeQue Vision Marker Screening

Products and services

  • EyeQue VERAI AI-powered at-home refraction measurement device that attaches to a smartphone and delivers clinically accurate DIY vision tests, producing doctor-reviewed prescriptions and Try-On glasses. Uses MIT-licensed adaptive AI technology with 24 granted patents.
  • EyeQue Insight Lite Pocket-sized vision screening device for at-home eye testing, measuring visual acuity, color vision, and contrast sensitivity with a portable form factor designed for frequent vision monitoring.
  • EyeQue PDCheck Physical pupillary distance measurement device consisting of a frame and app that uses a smartphone camera and selfie analysis to measure PD within 1mm accuracy for eyeglass fitting.
  • EyeQue PDCheck AR Free iOS app using Augmented Reality to instantly measure near and far pupillary distance, including right and left PD, using only an iPhone.
  • EyeQue MyReaderNumber iOS app that provides instant personalized near and mid-distance vision measurements for reading glasses using patented technology to measure reading and computer power for each eye individually.
  • EyeQue Try-On Glasses Single vision test glasses that allow users to try their refraction numbers before purchasing expensive prescription glasses, shipped with the EyeQue Insight Lite for visual acuity confirmation.
  • EyeQue Tracking Service Annual subscription service ($29/year) that tracks all vision measurements over time including refraction results (Sphere, Cylinder, Axis), PD measurements, and vision screening data (Visual Acuity, Contrast Sensitivity, Color Testing); HIPAA compliant.
  • EyeQue Connect FDA-registered, SOC2 and HIPAA-compliant telehealth SaaS platform that connects doctors and patients for remote vision care, with features including vision monitoring and tracking, virtual consultations, prescription management, automated reporting, and Open API EHR integration.
  • EyeQue Prescription Renewal Telehealth service enabling users to renew their prescription from home through a virtual consultation with a board-certified doctor based on EyeQue test results.
  • EyeQue Color Vision Test Free online color vision screening test that checks for red-green deficiencies (deuteranopia and protanopia) in 60 seconds, accessible without account login.
  • EyeQue Visual Acuity Test Free online visual acuity test using Snellen Chart methodology, accessible on desktop/laptop in under 5 minutes without requiring an account.

Quantifiable outcome

  • 95% of users achieve 20/20 visual acuity or better
  • +2 more outcomes

Companies that use EyeQue

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

EyeQue technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability6 records

Feature4 records

EyeQue partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • Zenni OpticalcoreStrategic or Co-development PartnerEyeQue founder Tibor Laczay discussed collaboration opportunities with Zenni Optical, a major online eyeglass retailer, for integrating vision testing capabilities with prescription eyeglass services. This partnership would enable Zenni customers to obtain updated prescriptions using EyeQue technology.
  • Access CarecoreStrategic or Co-development PartnerGroundbreaking alliance announced for providing vision care services. Access Care partnership enables expanded reach into specific market segments requiring vision care solutions.
  • Bath & Body WorksminorChannel Partner/ Reseller/ DistributorMentioned in alliance context with Access Care. Nature of partnership appears to involve distribution or retail presence for EyeQue products.
  • Optical Retail StorescoreChannel Partner/ Reseller/ DistributorPartnerships with optical retail stores for distribution, white labeling, and integration of EyeQue vision testing technology. Stores can offer EyeQue devices and telehealth services to their customers.
  • Telemedicine ProviderscoreTechnology or IntegrationIntegration partnerships with telemedicine platforms to offer remote vision testing and prescription services. EyeQue Connect platform enables telehealth consultations.
  • Hospitals and Healthcare OrganizationscoreTechnology or IntegrationPartnerships with hospitals and healthcare systems to provide scalable vision screening solutions. HIPAA-compliant infrastructure enables secure healthcare data handling.
  • Schools and Educational InstitutionsminorStrategic or Co-development PartnerPartnerships with schools for vision testing programs, providing accessible eye care screening for students.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

EyeQue competitors and assessment

Company assessment

Direct peers

  • Visibly (formerly Opternative): Visibly offers online refraction and prescription renewal services directly to consumers, the closest direct competitor to EyeQue's at-home vision testing model with doctor-reviewed prescriptions.
  • 20/20 Now: 20/20 Now provides online eye exams and refraction services partnering with optical retailers, directly overlapping EyeQue's telehealth vision testing and B2B white-label offerings.

Broad incumbents

  • Warby Parker: Warby Parker is an established direct-to-consumer eyewear retailer that has expanded into virtual try-on, prescription apps, and telehealth, competing with EyeQue on the consumer vision testing journey.
  • Zenni Optical: Zenni Optical is a major online eyeglass retailer; EyeQue has discussed partnership with them, and both companies target the prescription-eyewear self-service consumer segment.
  • 1-800 Contacts: 1-800 Contacts is the largest online contact lens retailer and has expanded into online vision testing and prescription renewal, overlapping with EyeQue's telehealth vision services.
  • eyeBuyDirect: eyeBuyDirect is a major online eyewear retailer offering prescription glasses; they have explored virtual try-on and prescription tools, overlapping with EyeQue's consumer vision testing value chain.
  • LensCrafters: LensCrafters is a large traditional optical retail chain owned by EssilorLuxottica, increasingly integrating digital refraction and telehealth into in-store and online experiences that compete with EyeQue's model.
  • SmartBuyGlasses: SmartBuyGlasses is an online eyewear retailer with a global presence offering prescription glasses; their digital try-on and prescription tools place them in the same consumer vision care space as EyeQue.

Emerging players

  • Hims & Hers Health: Hims & Hers has expanded into vision and eye care telehealth through online prescription eyewear, representing an emerging competitor in the broader digital vision care category.
  • RxDefine: RxDefine provides online vision testing and telehealth refraction services integrated with optical retail partners, an emerging player operating in a similar niche as EyeQue's telehealth vision testing.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

EyeQue social profiles

Digital presence

EyeQue compliance and trust

Trust signal

Compliance8 records

EyeQue financial estimates

Financial estimate

Revenue estimate

Valuation estimate

EyeQue leadership team

Management profile

Number of profiles

Profiles3 records

EyeQue funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

EyeQue M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EyeQue

What does EyeQue do?

EyeQue designs and sells smartphone-powered, AI-based at-home vision testing hardware and software, anchored by the VERAI refraction device. Its portfolio includes the Insight Lite screener, PDCheck and PDCheck AR pupillary distance tools, MyReaderNumber reading vision app, Try-On Glasses, the Tracking Service subscription, and the HIPAA-compliant EyeQue Connect telehealth platform with Open API for EHR integration, enabling consumers and partners to measure, track, and obtain prescriptions remotely.

Is EyeQue a public or private company?

EyeQue is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was EyeQue founded?

EyeQue was founded in 2015. It employs 11 to 50 people.

Where is EyeQue based?

EyeQue is headquartered in Newark, United States, in the North America region.

How does EyeQue make money?

Four revenue lines are on record. Hardware Device Sales are the primary driver. The others are subscription Services, telehealth and Prescription Services and B2B Licensing and White Labeling.

Who are EyeQue's main competitors?

Direct peers on record are Visibly (formerly Opternative) and 20/20 Now. Broad incumbents are Warby Parker, Zenni Optical, 1-800 Contacts, eyeBuyDirect, LensCrafters and SmartBuyGlasses. Emerging players are Hims & Hers Health and RxDefine.

Does EyeQue have an API?

Yes. EyeQue offers an Open API for seamless EHR integration that allows access to patient data. The API enables healthcare providers to connect their systems with EyeQue's telehealth platform for vision data retrieval and management. Developer documentation is at www.eyeque.com/telehealth-services.

What industry is EyeQue in?

EyeQue's product category is Consumer Digital Health Vision Testing. Its primary akta.pro industry code is HLAHAJAC, Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity), with a secondary code of HLALAGAL, Ophthalmology & Vision Telemedicine Platforms. Its NAICS code is 334510 and its SIC code is 3851.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EyequeRefraction Technology and The FutureEyeQue, a company promoting virtualized eye care, describes its portable VisionCheck device, which combines an autorefractor and phoropter into a palm-sized unit that uses a smartphone to measure refraction. The company says the device has passed clinical trials and performed over 250,000 eye tests worldwide, and is developing a binocular VisionCheck 3. Products are not sold in the United States.LaweeklyEyeQue is Making Eye Care Accessible to AllEyeQue, founded by John Serri and Tibor Laczay, develops smartphone-based eye health devices. The company pivoted to a B2B model with HIPAA-compliant SaaS, and aims to make at-home eye testing accessible. It has unicorn potential and is developing next-generation devices.CNETGive Yourself an Eye Exam Right From Your SmartphoneEyeQue has developed the VisionCheck device, which attaches to a smartphone and uses MIT-patented technology to allow users to measure their vision and obtain 'Eyeglass Numbers' for online glasses purchases. The device is priced at $80 with an annual membership fee, though it explicitly does not replace comprehensive annual eye exams conducted by optometrists. Independent testing suggests the device can provide reasonable estimates for minor refractive errors but requires user adaptation to operate effectively.NewswireEyeQue Gives BackEyeQue donated 25,000 Personal Vision Trackers to the Oklahoma City Indian Clinic. The clinic serves over 22,000 patients annually from more than 200 federally recognized tribes. The donation aims to help meet the vision needs of the clinic's growing patient population.GlobeNewswireEyeQue Gives BackEyeQue donated 25,000 Personal Vision Trackers to the Oklahoma City Indian Clinic, a non-profit serving over 22,000 patients annually. The clinic's optometrist said at-home vision tests improve accessibility and early detection of vision changes. EyeQue, founded in 2015, aims to make clear vision a right.NewswireEyeQue to Present Award Winning Solutions and More at CES 2023EyeQue will showcase its award-winning vision testing solutions at CES 2023, including consumer devices, institutional products, and a HIPAA-compliant cloud platform. The company will also debut a one-stop-shop concept for home testing and eyeglass purchases. Booth 8455 at the Las Vegas Convention Center.GlobeNewswireEyeQue to Present Award Winning Solutions and More at CES 2023EyeQue will showcase its vision testing products at CES 2023, including consumer and institutional devices and a HIPAA-compliant cloud platform. The company will debut a one-stop-shop concept for home testing and prescription, and will be at booth 8455 at the Las Vegas Convention Center.The Mac ObserverEyeQue Launches AR Vision App ‘MyReaderNumber’EyeQue launched MyReaderNumber, an AR-powered vision app for near- and mid-distance vision tests, priced at US$2.99. The app uses patent-pending AR technology to measure distances and recommend magnification for reading or computer use, with results shareable with doctors.Business Wire BlogIntroducing the EyeQue MyReaderNumber App: Personalized Results for Reading and Computer GlassesEyeQue launched MyReaderNumber, an AR-powered smartphone app for testing near and mid-distance vision in presbyopia. The app costs $2.99 on iOS and provides personalized magnification results, with results shareable with doctors. It is patent-pending and registered with the FDA as a class I medical device.Apple World TodayNew MyReaderNumber App offers Personalized Results for Reading and Computer GlassesEyeQue launched MyReaderNumber, an iPhone app using AR to test for presbyopia, affecting 128 million Americans. The app provides personalized near and mid-distance measurements for over-the-counter readers, priced at $2.99. Users can share results with doctors or purchase glasses.